MedPath

Optimal diet patterns for improving muscle strength in older adults

Not Applicable
Completed
Conditions
oss of muscle mass and strength in aging
Loss of muscle mass and strength in aging
Musculoskeletal - Other muscular and skeletal disorders
Registration Number
ACTRN12612000177853
Lead Sponsor
niversity of South Australia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
135
Inclusion Criteria

Aged 50-79 yrs
BMI 20-35 kg/m2
Stable medication for at least 3 months

Exclusion Criteria

Diagnosed with diabetes (type 1 or type 2 diabetes), proteinuria, a malignancy, or a history of metabolic disease such as liver, kidney, cardiovascular, respiratory or gastrointestinal disease, cardiac abnormalities or are pregnant or lactating
Uncontrolled hypertension
Currently have or history of a musculoskeletal injury, joint or peripheral vascular disease sufficient to impede their participation in the exercise program (such as hip arthritis, foot, ankle problems or pain)
Current smoker or history of smoking during last 6 months Heavy alcohol consumption (> 5 STD drinks/day) or unable to limit intake for study duration (upper limit of 2-7 STD drinks/wk)
Participated in regular formal aerobic or resistance exercise program (greater than two 30-min sessions of moderate/vigorous aerobic exercise per week or greater than 1 moderate intensity resistance exercise session per week) during the 6 months prior to study
Widely fluctuating exercise patterns
Currently on a weight reducing diet
Intolerant/allergic to lactose or bovine milk protein
Untreated depression
Currently using or recent (3 months) use of testosterone therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in 1 repetition maximum of chest press, lateral pull down, leg press, knee extension and leg curl assessed on gym equipment[There are 2 timepoints, baseline (week 0) and at the end of the intervention at Week 12]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath